-
1
-
-
0035162772
-
The gut as the largest endocrine organ in the body.
-
Ahlman, H., & Nilsson, O. (2001). The gut as the largest endocrine organ in the body. Annals of Oncology, 12(Suppl. 2), S63-S68.
-
(2001)
Annals of Oncology
, vol.12
, pp. S63-S68
-
-
Ahlman, H.1
Nilsson, O.2
-
2
-
-
0033561077
-
ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery.
-
American Society of Health-System Pharmacists (ASHP). (1999). ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. American Journal of Health-System Pharmacy, 56(8), 729-764.
-
(1999)
American Journal of Health-System Pharmacy
, vol.56
, Issue.8
, pp. 729-764
-
-
-
3
-
-
85026135852
-
-
Andrews, P. L. R., & Davis, C. J. (1993). Chapter 7: The mechanism of emesis induced by anti-cancer therapies (113-161). In P. L. R. Andrews, & G. J. Sanger (Eds.), Emesis in anti-cancer therapy: Mechanisms and treatment. London: Chapman & Hall Medical.
-
Andrews, P. L. R., & Davis, C. J. (1993). Chapter 7: The mechanism of emesis induced by anti-cancer therapies (113-161). In P. L. R. Andrews, & G. J. Sanger (Eds.), Emesis in anti-cancer therapy: Mechanisms and treatment. London: Chapman & Hall Medical.
-
-
-
-
4
-
-
0031900769
-
Neuropharmacology of emesis and its relevance to anti-emetic therapy: Consensus and controversies.
-
Andrews, P. L. R., Naylor, R. J., & Joss, R. A. (1998). Neuropharmacology of emesis and its relevance to anti-emetic therapy: Consensus and controversies. Supportive Care in Cancer, 6(3), 197-203.
-
(1998)
Supportive Care in Cancer
, vol.6
, Issue.3
, pp. 197-203
-
-
Andrews, P.L.R.1
Naylor, R.J.2
Joss, R.A.3
-
5
-
-
0023753440
-
Neuropharmacology of emesis induced by anti-cancer therapy.
-
Andrews, P. L. R., Rapeport, W. G., & Sanger, G. J. (1988). Neuropharmacology of emesis induced by anti-cancer therapy. Trends in Pharmacological Research, 9(9), 334-341.
-
(1988)
Trends in Pharmacological Research
, vol.9
, Issue.9
, pp. 334-341
-
-
Andrews, P.L.R.1
Rapeport, W.G.2
Sanger, G.J.3
-
6
-
-
77049144409
-
Physiology and pharmacology of vomiting.
-
Borison, H. L., & Wang, S. C. (1953). Physiology and pharmacology of vomiting. Pharmacological Review, 5(5), 193-220.
-
(1953)
Pharmacological Review
, vol.5
, Issue.5
, pp. 193-220
-
-
Borison, H.L.1
Wang, S.C.2
-
7
-
-
0027078370
-
Mechanisms by which cancer chemotherapeutic drugs induce emesis.
-
Cubeddu, L. X. (1992). Mechanisms by which cancer chemotherapeutic drugs induce emesis. Seminars in Oncology, 19(Suppl 15), 2-13.
-
(1992)
Seminars in Oncology
, vol.19
, pp. 2-13
-
-
Cubeddu, L.X.1
-
8
-
-
1842790093
-
Aprepitent: A review of its use in the prevention of chemotherapy-induced nausea and vomiting.
-
Dando, T. M., & Perry, C. M. (2004). Aprepitent: A review of its use in the prevention of chemotherapy-induced nausea and vomiting. Drugs, 64(7), 777-794.
-
(2004)
Drugs
, vol.64
, Issue.7
, pp. 777-794
-
-
Dando, T.M.1
Perry, C.M.2
-
9
-
-
0037561044
-
Current position of 5-HT3 antagonists and the additional value of NK1 antagonists: A new class of antiemetics.
-
1 antagonists: A new class of antiemetics. British Journal of Cancer, 88(12), 1823-1827.
-
(2003)
British Journal of Cancer
, vol.88
, Issue.12
, pp. 1823-1827
-
-
de Wit, R.1
-
10
-
-
0346556083
-
-
1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy. Journal of Clinical Oncology, 21(22), 4105-4111.
-
1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy. Journal of Clinical Oncology, 21(22), 4105-4111.
-
-
-
-
11
-
-
0033774032
-
Potential of substance P antagonists as antiemetics.
-
Diemunsch, P., & Grelot, L. (2000). Potential of substance P antagonists as antiemetics. Drugs, 60(3), 533-546.
-
(2000)
Drugs
, vol.60
, Issue.3
, pp. 533-546
-
-
Diemunsch, P.1
Grelot, L.2
-
12
-
-
0141761458
-
Options for the prevention and management of acute chemotherapy-induced nausea and vomiting in children.
-
Dupuis, L. L., & Nathan, P. C. (2003). Options for the prevention and management of acute chemotherapy-induced nausea and vomiting in children. Pediatric Drugs, 5(9), 597-613.
-
(2003)
Pediatric Drugs
, vol.5
, Issue.9
, pp. 597-613
-
-
Dupuis, L.L.1
Nathan, P.C.2
-
14
-
-
33748747008
-
Chemotherapy-induced nausea vomiting: Research update on improving control.
-
Fromer, M. J. (2005). Chemotherapy-induced nausea & vomiting: Research update on improving control. Oncology Times, 27(1), 19-23.
-
(2005)
Oncology Times
, vol.27
, Issue.1
, pp. 19-23
-
-
Fromer, M.J.1
-
15
-
-
0033550693
-
The site of the anti-emetic action of tachykinin NK1 receptor antagonists may exist in the medullary area adjacent to the semicompact part of the nucleus ambiguus.
-
Fukunda, H., Nakamura, E., Koga, T., Furukawa, N., & Shiroshita, Y. (1999). The site of the anti-emetic action of tachykinin NK1 receptor antagonists may exist in the medullary area adjacent to the semicompact part of the nucleus ambiguus. Brain Research, 818(2), 439-449.
-
(1999)
Brain Research
, vol.818
, Issue.2
, pp. 439-449
-
-
Fukunda, H.1
Nakamura, E.2
Koga, T.3
Furukawa, N.4
Shiroshita, Y.5
-
16
-
-
0036413427
-
5-HT3-receptor antagonists for the treatment of nausea and nausea and vomiting: A reappraisal of their side-effect profile.
-
3-receptor antagonists for the treatment of nausea and nausea and vomiting: A reappraisal of their side-effect profile. Oncologist, 7(5), 424-436.
-
(2002)
Oncologist
, vol.7
, Issue.5
, pp. 424-436
-
-
Goodin, S.1
Cunningham, R.2
-
17
-
-
0036124257
-
-
Gralla, R. J. (2002). New agents, new treatment, and antiemetic therapy. Seminars in Oncology, 29(1, Suppl 4), 199-124.
-
Gralla, R. J. (2002). New agents, new treatment, and antiemetic therapy. Seminars in Oncology, 29(1, Suppl 4), 199-124.
-
-
-
-
18
-
-
0032847992
-
-
Gralla, R. J., Osoba, D., Kris, M. G., Kirkbride, P., Hesketh, P. J., Chinnery, L. W., et al. (1999). Recommendations for the use of antiemetics: Evidence-based clinical practice guidelines. Journal of Clinical Oncology, 17(9), 2971-2994.
-
Gralla, R. J., Osoba, D., Kris, M. G., Kirkbride, P., Hesketh, P. J., Chinnery, L. W., et al. (1999). Recommendations for the use of antiemetics: Evidence-based clinical practice guidelines. Journal of Clinical Oncology, 17(9), 2971-2994.
-
-
-
-
19
-
-
16644388026
-
New developments in the management of chemotherapy-induced emesis: Do they impact on existing guidelines? Oncology, 18(10 Suppl.
-
Grunberg, S. M. (2004). New developments in the management of chemotherapy-induced emesis: Do they impact on existing guidelines? Oncology, 18(10 Suppl.), 15-19.
-
(2004)
, vol.15
, pp. 19
-
-
Grunberg, S.M.1
-
20
-
-
16644377501
-
Understanding the pathobiology of chemotherapy-induced nausea and vomiting: Providing a basis for therapeutic progress. Oncology, 18(10 Suppl.
-
Hesketh, P. J. (2004). Understanding the pathobiology of chemotherapy-induced nausea and vomiting: Providing a basis for therapeutic progress. Oncology, 18(10 Suppl.), 9-14.
-
(2004)
, vol.9
, pp. 14
-
-
Hesketh, P.J.1
-
21
-
-
0347816226
-
-
Hesketh, P. J., Grunberg, S. M., Gralla, R. J., Warr, D. G., Roila, F., de Wit, R., et al. (2003). The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: A multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin-The aprepitant protocol 052 study group. Journal of Clinical Oncology, 21(22), 4112-4119.
-
Hesketh, P. J., Grunberg, S. M., Gralla, R. J., Warr, D. G., Roila, F., de Wit, R., et al. (2003). The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: A multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin-The aprepitant protocol 052 study group. Journal of Clinical Oncology, 21(22), 4112-4119.
-
-
-
-
22
-
-
0031025087
-
-
Hesketh, P. J., Kris, M. G., Grunberg, S. M., Beck, T., Hainsworth, J. D., Harker, G., et al. (1997). Proposal for classifying the acute emetogenicity of cancer chemotherapy. Journal of Clinical Oncology, 15(1), 103-109.
-
Hesketh, P. J., Kris, M. G., Grunberg, S. M., Beck, T., Hainsworth, J. D., Harker, G., et al. (1997). Proposal for classifying the acute emetogenicity of cancer chemotherapy. Journal of Clinical Oncology, 15(1), 103-109.
-
-
-
-
23
-
-
0025455312
-
Patterns of nausea and vomiting in children: Nursing assessment and intervention.
-
Hockenberry-Eaton, M., & Benner, A. (1990). Patterns of nausea and vomiting in children: Nursing assessment and intervention. Oncology Nursing Forum, 17(4), 575-584.
-
(1990)
Oncology Nursing Forum
, vol.17
, Issue.4
, pp. 575-584
-
-
Hockenberry-Eaton, M.1
Benner, A.2
-
24
-
-
0031204451
-
Physiologic mechanisms of nausea and vomiting in patients with cancer.
-
Hogan, C. M., & Grant, M. (1997). Physiologic mechanisms of nausea and vomiting in patients with cancer. Oncology Nursing Forum, 24(7), 8-12.
-
(1997)
Oncology Nursing Forum
, vol.24
, Issue.7
, pp. 8-12
-
-
Hogan, C.M.1
Grant, M.2
-
25
-
-
0033253113
-
Self-regulation theory and coping with physical illness.
-
Johnson, J. E. (1999). Self-regulation theory and coping with physical illness. Research in Nursing & Health, 22(6), 435-448.
-
(1999)
Research in Nursing Health
, vol.22
, Issue.6
, pp. 435-448
-
-
Johnson, J.E.1
-
26
-
-
0031204801
-
Nonpharmacologic management of chemotherapy-induced nausea and vomiting.
-
King, C. R. (1997). Nonpharmacologic management of chemotherapy-induced nausea and vomiting. Oncology Nursing Forum, 24(Suppl. 7), S41-S48.
-
(1997)
Oncology Nursing Forum
, vol.24
, pp. S41-S48
-
-
King, C.R.1
-
27
-
-
0036933329
-
-
Koeller, J. M., Aapro, M. S., Gralla, R. S., Grunberg, S. M., Hesketh, P. J., Kris, M. G., et al. (2002). Antiemetic guidelines: Creating a more practical treatment approach. Supportive Care of Cancer, 10(7), 519-522.
-
Koeller, J. M., Aapro, M. S., Gralla, R. S., Grunberg, S. M., Hesketh, P. J., Kris, M. G., et al. (2002). Antiemetic guidelines: Creating a more practical treatment approach. Supportive Care of Cancer, 10(7), 519-522.
-
-
-
-
28
-
-
85026153606
-
-
Leslie, R. A., & Reynolds, D. J. M. (1993). Chapter 6: Neurotransmitters and receptors in the emetic pathway. In P. L. R. Andrews, & G. J. Sanger (Eds.), Emesis in anti-cancer therapy. London: Chapman & Hall Medical.
-
Leslie, R. A., & Reynolds, D. J. M. (1993). Chapter 6: Neurotransmitters and receptors in the emetic pathway. In P. L. R. Andrews, & G. J. Sanger (Eds.), Emesis in anti-cancer therapy. London: Chapman & Hall Medical.
-
-
-
-
29
-
-
0042787587
-
Antiemetic therapy in patients receiving cancer chemotherapy.
-
Marek, C. (2003). Antiemetic therapy in patients receiving cancer chemotherapy. Oncology Nursing Forum, 30(2), 259-269.
-
(2003)
Oncology Nursing Forum
, vol.30
, Issue.2
, pp. 259-269
-
-
Marek, C.1
-
30
-
-
0031255395
-
Controlling conditioning-related emesis in children undergoing bone marrow transplantation.
-
Mehta, N. H., Reed, C. M., Kuhlman, C., Weinstein, H. J., & Parsons, S. K. (1997). Controlling conditioning-related emesis in children undergoing bone marrow transplantation. Oncology Nursing Forum, 24(9), 1539-1544.
-
(1997)
Oncology Nursing Forum
, vol.24
, Issue.9
, pp. 1539-1544
-
-
Mehta, N.H.1
Reed, C.M.2
Kuhlman, C.3
Weinstein, H.J.4
Parsons, S.K.5
-
31
-
-
0038175313
-
Improving the care of patients with regard to chemotherapy-induced nausea and emesis: The effect of feedback to clinicians on adherence to antiemetic presenting guidelines.
-
Mertens, W. C., Higby, D. J., Brown, D., Parisi, R., Fitzgerald, J., Benjamin, E. M., & Lindenauer, P. K. (2003). Improving the care of patients with regard to chemotherapy-induced nausea and emesis: The effect of feedback to clinicians on adherence to antiemetic presenting guidelines. Journal of Clinical Oncology, 21(7), 1373-1378.
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.7
, pp. 1373-1378
-
-
Mertens, W.C.1
Higby, D.J.2
Brown, D.3
Parisi, R.4
Fitzgerald, J.5
Benjamin, E.M.6
Lindenauer, P.K.7
-
32
-
-
0021247694
-
The assessment of nausea and vomiting: Past problems, current issues, and suggestions for future research.
-
Morrow, G. R. (1984). The assessment of nausea and vomiting: Past problems, current issues, and suggestions for future research. Cancer, 53(Suppl. 10), 2267-2278.
-
(1984)
Cancer
, vol.53
, pp. 2267-2278
-
-
Morrow, G.R.1
-
33
-
-
85026135560
-
-
Retrieved May 9, 2003, from
-
Morrow, G. R. (2003). Chemotherapy-related nausea and vomiting. In M. B. Max & J. Lynn (Eds.), Interactive textbook on clinical management. (Online at Symptom Research Interactive Research Textbook website).
-
-
-
-
34
-
-
0036936555
-
Nausea and emesis: Evidence for a biobehavioral perspective.
-
Morrow, G. R., Roscoe, J. A., Hickok, J. T., Andrews, P. L. R., & Matteson, S. (2002). Nausea and emesis: Evidence for a biobehavioral perspective. Supportive Care in Cancer, 10(2), 96-105.
-
(2002)
Supportive Care in Cancer
, vol.10
, Issue.2
, pp. 96-105
-
-
Morrow, G.R.1
Roscoe, J.A.2
Hickok, J.T.3
Andrews, P.L.R.4
Matteson, S.5
-
35
-
-
0031691344
-
Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the Perugia Consensus Conference.
-
Multinational Association of Supportive Care in Cancer (MASCC), Antiemetics Subcommittee. (1998). Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the Perugia Consensus Conference. Annals of Oncology, 9(8), 811-819.
-
(1998)
Annals of Oncology
, vol.9
, Issue.8
, pp. 811-819
-
-
-
36
-
-
85026148144
-
-
Retrieved September 30, 2002, from
-
National Comprehensive Cancer Network (NCCN) Antiemesis Panel. (2001, January 30). Antiemesis; version 1.2001. NCCN: Practice guidelines in oncology.
-
-
-
-
37
-
-
0029788231
-
Mechanisms of chemotherapy/radiotherapy-induced emesis in animal models.
-
Naylor, R. J., & Rudd, J. A. (1996). Mechanisms of chemotherapy/radiotherapy-induced emesis in animal models. Oncology, 53(Suppl. 1), 8-17.
-
(1996)
Oncology
, vol.53
, pp. 8-17
-
-
Naylor, R.J.1
Rudd, J.A.2
-
38
-
-
1842590585
-
Aprepitant in antiemetic combinations to prevent chemotherapy-induced nausea and vomiting.
-
Olver, I. N. (2004). Aprepitant in antiemetic combinations to prevent chemotherapy-induced nausea and vomiting. International Journal of Clinical Practice, 58(2), 201-206.
-
(2004)
International Journal of Clinical Practice
, vol.58
, Issue.2
, pp. 201-206
-
-
Olver, I.N.1
-
39
-
-
85026142711
-
-
Purl, S., & Wickham, R. (2002). Managing chemotherapy-related nausea: Evidence-based approaches. (Workbook for interactive audioconference, ROC-9). Monmouth Junction, NJ: Interactive Network for Continuing Education.
-
Purl, S., & Wickham, R. (2002). Managing chemotherapy-related nausea: Evidence-based approaches. (Workbook for interactive audioconference, ROC-9). Monmouth Junction, NJ: Interactive Network for Continuing Education.
-
-
-
-
40
-
-
0033146925
-
The index of nausea, vomiting, and retching: A new format of the index of nausea and vomiting.
-
Rhodes, V. A., & McDaniel, R. W. (1999). The index of nausea, vomiting, and retching: A new format of the index of nausea and vomiting. Oncology Nursing Forum, 26(5), 889-894.
-
(1999)
Oncology Nursing Forum
, vol.26
, Issue.5
, pp. 889-894
-
-
Rhodes, V.A.1
McDaniel, R.W.2
-
41
-
-
8844237504
-
Patient expectation is a strong predictor of severe nausea after chemotherapy.
-
Roscoe, J. A., Bushunow, P., Morrow, G. R., Hickok, J. T., Kuebler, P. J., Jacobs, A., & Banerjee, T. K. (2004). Patient expectation is a strong predictor of severe nausea after chemotherapy. Cancer, 101(11), 2701-2708.
-
(2004)
Cancer
, vol.101
, Issue.11
, pp. 2701-2708
-
-
Roscoe, J.A.1
Bushunow, P.2
Morrow, G.R.3
Hickok, J.T.4
Kuebler, P.J.5
Jacobs, A.6
Banerjee, T.K.7
-
42
-
-
85026140696
-
-
Rudd, J. A., & Andrews, P. L. R. (2005). Chapter 2: Mechanisms of acute, delayed, and anticipatory emesis induced by anticancer therapies. In P. J. Hesketh (Ed.), Management of nausea and vomiting in cancer and cancer treatment. Sudbury, MA: Jones and Bartlett Publishers.
-
Rudd, J. A., & Andrews, P. L. R. (2005). Chapter 2: Mechanisms of acute, delayed, and anticipatory emesis induced by anticancer therapies. In P. J. Hesketh (Ed.), Management of nausea and vomiting in cancer and cancer treatment. Sudbury, MA: Jones and Bartlett Publishers.
-
-
-
-
43
-
-
0037258090
-
Chemotherapy-induced nausea and vomiting: The importance of acute antiemetic control.
-
Schnell, F. M. (2003). Chemotherapy-induced nausea and vomiting: The importance of acute antiemetic control. Oncologist, 8(2), 187-198.
-
(2003)
Oncologist
, vol.8
, Issue.2
, pp. 187-198
-
-
Schnell, F.M.1
-
44
-
-
2942601362
-
Palonosetron.
-
Siddiqui, M. A. A., & Scott, L J. (2004). Palonosetron. Drugs, 64(10), 1125-1132.
-
(2004)
Drugs
, vol.64
, Issue.10
, pp. 1125-1132
-
-
Siddiqui, M.A.A.1
Scott, L.J.2
-
45
-
-
0037737739
-
The ups and downs of novel antiemetic drugs, part 1: Substance P, 5-HT, and the neuropharmacology of vomiting.
-
Stahl, S. M. (2003). The ups and downs of novel antiemetic drugs, part 1: Substance P, 5-HT, and the neuropharmacology of vomiting. Journal of Clinical Psychiatry, 64(5), 498-499.
-
(2003)
Journal of Clinical Psychiatry
, vol.64
, Issue.5
, pp. 498-499
-
-
Stahl, S.M.1
-
46
-
-
13844280916
-
Developments in antiemetic therapy.
-
Stenger, M. (2004). Developments in antiemetic therapy. Community Oncology, 1(2), 79-81.
-
(2004)
Community Oncology
, vol.1
, Issue.2
, pp. 79-81
-
-
Stenger, M.1
-
47
-
-
0031014883
-
Physiology of chemotherapy-induced emesis and antiemetic therapy: Predictive models for evaluation of new compounds.
-
Veyrat-Follet, C., Farinotti, R., & Palmer, J. L. (1997). Physiology of chemotherapy-induced emesis and antiemetic therapy: Predictive models for evaluation of new compounds. Drugs, 53(2), 206-234.
-
(1997)
Drugs
, vol.53
, Issue.2
, pp. 206-234
-
-
Veyrat-Follet, C.1
Farinotti, R.2
Palmer, J.L.3
-
48
-
-
85026155000
-
-
Wickham, R. (2003). Nausea and vomiting in cancer.
-
Wickham, R. (2003). Nausea and vomiting in cancer.
-
-
-
|